UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
ASSETS
Cash and cash equivalents	$ 24,128	$ 12,966
Restricted cash and equivalents	129,450	104,445
Finance receivables	1,081,282	764,343
Less: Allowance for finance credit losses	(34,464)	(19,594)
Finance receivables, net	1,046,818	744,749
Finance receivables measured at fair value	21,217	59,668
Residual interest in securitizations	1,426	4,824
Furniture and equipment, net	607	726
Deferred financing costs	11,163	9,140
Deferred tax assets, net	66,166	75,640
Accrued interest receivable	15,146	10,411
Other assets	17,391	15,051
Total	1,333,512	1,037,620
Liabilities
Accounts payable and accrued expenses	33,817	17,785
Warehouse lines of credit	26,959	21,731
Residual interest financing	20,000	13,773
Debt secured by receivables measured at fair value	16,888	57,107
Securitization trust debt	1,094,559	792,497
Senior secured debt, related party	38,963	50,135
Subordinated renewable notes	20,640	23,281
Total	1,251,826	976,309
COMMITMENTS AND CONTINGENCIES
Shareholders' Equity
Preferred stock, $1 par value; authorized 4,998,130 shares; none issued Series A preferred stock, $1 par value; authorized 5,000,000 shares; none issued Series B preferred stock, $1 par value; authorized 1,870 shares; none issued
Common stock, no par value; authorized 75,000,000 shares; 22,150,560 and 19,838,913 shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively	71,570	65,678
Retained earnings	15,753	1,270
Accumulated other comprehensive loss	(5,637)	(5,637)
Total	81,686	61,311
Total	1,333,512	1,037,620
Series A Preferred Stock [Member]
Shareholders' Equity
Preferred stock, $1 par value; authorized 4,998,130 shares; none issued Series A preferred stock, $1 par value; authorized 5,000,000 shares; none issued Series B preferred stock, $1 par value; authorized 1,870 shares; none issued	0	0
Series B Preferred Stock [Member]
Shareholders' Equity
Preferred stock, $1 par value; authorized 4,998,130 shares; none issued Series A preferred stock, $1 par value; authorized 5,000,000 shares; none issued Series B preferred stock, $1 par value; authorized 1,870 shares; none issued	$ 0	$ 0